Effect of desmopressin on platelet aggregation and blood loss in patients undergoing valvular heart surgery

Chinese Medical Journal

Volumn 128, Issue 5, 2015, Pages 644-647

  Jin, Lei ^a   Ji, Hong Wen ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

Blood loss; Blood transfusion; Cardiac surgery; Desmopressin; Platelet aggregation

Indexed keywords

ADENOSINE DIPHOSPHATE; ARACHIDONIC ACID; BLOOD CLOTTING FACTOR 8; DESMOPRESSIN; FRESH FROZEN PLASMA; HEMOGLOBIN; VON WILLEBRAND FACTOR; ARGIPRESSIN[1 DEAMINO];

ADULT; ARTICLE; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; DRUG EFFICACY; ERYTHROCYTE TRANSFUSION; FEMALE; FOLLOW UP; HEART VALVE SURGERY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PLASMA TRANSFUSION; POSTOPERATIVE HEMORRHAGE; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; URINE VOLUME; DRUG EFFECTS; HEART SURGERY; HEMORRHAGE; MIDDLE AGED; PROCEDURES;

ADULT; CARDIAC SURGICAL PROCEDURES; DEAMINO ARGININE VASOPRESSIN; FEMALE; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION;

EID: 84923341317     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.4103/0366-6999.151663     Document Type: Article

References (11)

1. Cash JD, Gader AM, da Costa J. Proceedings: The release of plasminogen activator and factor VIII to lysine vasopressin, arginine vasopressin, I-desamino-8-d-arginine vasopressin, angiotensin and oxytocin in man. Br J Haematol 1974;27:363-4.
2. Sadler JE, Mannucci PM, Berntorp E, Bochkov N, Boulyjenkov V, Ginsburg D, et al. Impact, diagnosis and treatment of von Willebrand disease. Thromb Haemost 2000;84:160-74.
3. Mannucci PM. Desmopressin (DDAVP) in the treatment of bleeding disorders: The first 20 years. Blood 1997;90:2515-21.
4. Society of Thoracic Surgeons Blood Conservation Guideline Task Force, Ferraris VA, Ferraris SP, Saha SP, Hessel EA 2nd, Haan CK, et al. Perioperative blood transfusion and blood conservation in cardiac surgery: The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Clinical Practice Guideline. Ann Thorac Surg 2007;83:S27-86.
5. Menkis AH, Martin J, Cheng DC, Fitzgerald DC, Freedman JJ, Gao C, et al. Drug, devices, technologies, and techniques for blood management in minimally invasive and conventional cardiothoracic surgery: A consensus statement from the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) 2011. Innovations (Phila) 2012;7:229-41.
6. Carless PA, Henry DA, Moxey AJ, O’Connell D, McClelland B, Henderson KM, et al. Desmopressin for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2004;1:CD001884.
7. Barnhart MI, Chen S, Lusher JM. DDAVP: Does the drug have a direct effect on the vessel wall? Thromb Res 1983;31:239-53.
8. Sakariassen KS, Cattaneo M, vd Berg A, Ruggeri ZM, Mannucci PM, Sixma JJ. DDAVP enhances platelet adherence and platelet aggregate growth on human artery subendothelium. Blood 1984;64:229-36.
9. Andersson TL, Solem JO, Tengborn L, Vinge E. Effects of desmopressin acetate on platelet aggregation, von Willebrand factor, and blood loss after cardiac surgery with extracorporeal circulation. Circulation 1990;81:872-8.
10. Weber CF, Dietrich W, Spannagl M, Hofstetter C, Jámbor C. A point-of-care assessment of the effects of desmopressin on impaired platelet function using multiple electrode whole-blood aggregometry in patients after cardiac surgery. Anesth Analg 2010;110:702-7.
11. Dunn AL, Powers JR, Ribeiro MJ, Rickles FR, Abshire TC. Adverse events during use of intranasal desmopressin acetate for haemophilia A and von Willebrand disease: A case report and review of 40 patients. Haemophilia 2000;6:11-4.